Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors (Q35025067)

5 August 2017

title

Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors (English)

1 reference

Soluble epoxide hydrolase

5 August 2017

main subject

0 references

author name string

Kara R Schmelzer

1

1 reference

5 August 2017

Bora Inceoglu

2

1 reference

5 August 2017

Lukas Kubala

3

1 reference

5 August 2017

In-Hae Kim

4

1 reference

5 August 2017

Steven L Jinks

5

1 reference

5 August 2017

Jason P Eiserich

6

1 reference

5 August 2017

Bruce D Hammock

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Proceedings of the National Academy of Sciences of the United States of America

5 August 2017

published in

1 reference

5 August 2017

volume

103

1 reference

5 August 2017

issue

37

1 reference

5 August 2017

page(s)

13646-13651

1 reference

Soluble epoxide hydrolase is a therapeutic target for acute inflammation

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Coxibs and cardiovascular disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Selective inhibitors of cyclooxygenase-2 delay the activation of nuclear factor kappa B and attenuate the expression of inflammatory genes in murine macrophages treated with lipopolysaccharide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Patient-controlled analgesia with morphine plus lysine acetyl salicylate

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Pharmacological analysis of cyclooxygenase-1 in inflammation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Non-steroidal anti-inflammatory drugs and spinal nociceptive processing

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564210

An isobolographic analysis of the adrenergic modulation of diclofenac antinociception

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0605908103

Risk reduction therapies for patients with coronary artery disease: a call for increased implementation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0605908103

Gastrointestinal damage induced by celecoxib and rofecoxib in rats

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0605908103

The cellular association of sodium salicylate and indomethacin in peritoneal fluid of ascites bearing mice

21 January 2018

1 reference

12 December 2020

Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids

1 reference

12 December 2020

Ketorolac potentiates morphine in postoperative patient-controlled analgesia

1 reference

12 December 2020

Inducible cyclooxygenase may have anti-inflammatory properties

1 reference

12 December 2020

Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0605908103

1 reference

5 August 2017

0 references

1 reference

5 August 2017

1 reference